StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Adaptive Biotechnologies Corporation
NasdaqGS:ADPT
Sector
Location
Market Cap
USD 1.58 B
Share Price
USD 10.39
Avg Daily Volume
2,234,471
Change (1 day)
-1.05%
Change (1 year)
145.63%
Change (YTD)
73.17%
Adaptive Biotechnologies Corporation EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -71.88%
Adaptive Biotechnologies Corporation EBIT Margin is -71.88% for the Trailing 12 Months (TTM) ending March 31, 2025, a -37.87% change year over year. EBIT ratio is the ratio of EBIT to revenue, measuring a company's operating profitability without considering non-operating income or expenses.
-
Adaptive Biotechnologies Corporation EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -115.69%, a 13.27% change year over year.
-
Adaptive Biotechnologies Corporation EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -102.13%, a -32.46% change year over year.
-
Adaptive Biotechnologies Corporation EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -151.23%, a 8.74% change year over year.
-
Adaptive Biotechnologies Corporation EBIT Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -139.08%, a 42.12% change year over year.
Competitors
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Moderna, Inc.
USD 31.26
MRNA
-0.94
-2.92%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.36
603392.SS
+0.02
0.20%
Swedish Orphan Biovitrum AB (publ)
USD 28.00
SOBI.ST
-0.22
-0.79%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.84
300122.SZ
-0.01
-0.52%
Ionis Pharmaceuticals, Inc.
USD 41.76
IONS
-0.41
-0.97%
Rhythm Pharmaceuticals, Inc.
USD 89.20
RYTM
-1.48
-1.63%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.21
1877.HK
+0.01
0.41%
Vaxcyte, Inc.
USD 36.21
PCVX
-1.16
-3.10%
Hualan Biological Engineering Inc.
USD 2.26
002007.SZ
+0.00
0.20%
Ligand Pharmaceuticals Incorporated
USD 139.10
LGND
+1.53
1.11%
Apellis Pharmaceuticals, Inc.
USD 19.47
APLS
-0.57
-2.84%
NewAmsterdam Pharma Company N.V.
USD 22.20
NAMS
+0.22
1.00%
Apogee Therapeutics, Inc.
USD 39.31
APGE
+0.31
0.80%
Bavarian Nordic A/S
USD 28.67
BAVA.CO
+0.39
1.37%
Immunocore Holdings plc
USD 36.31
IMCR
+0.10
0.28%
ARS Pharmaceuticals, Inc.
USD 17.92
SPRY
-0.43
-2.34%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Novo Nordisk A/S
USD 64.39
NOVO-B.CO
-1.34
-2.03%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%
Key Data
| Date | EBIT Margin | EBITDA Margin | Net Income Margin | EBT Margin |
|---|
Competitors
Sanofi
USD 96.63
SAN.PA
-0.24
-0.24%
Moderna, Inc.
USD 31.26
MRNA
-0.94
-2.92%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.36
603392.SS
+0.02
0.20%
Swedish Orphan Biovitrum AB (publ)
USD 28.00
SOBI.ST
-0.22
-0.79%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.84
300122.SZ
-0.01
-0.52%
Ionis Pharmaceuticals, Inc.
USD 41.76
IONS
-0.41
-0.97%
Rhythm Pharmaceuticals, Inc.
USD 89.20
RYTM
-1.48
-1.63%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.21
1877.HK
+0.01
0.41%
Vaxcyte, Inc.
USD 36.21
PCVX
-1.16
-3.10%
Hualan Biological Engineering Inc.
USD 2.26
002007.SZ
+0.00
0.20%
Ligand Pharmaceuticals Incorporated
USD 139.10
LGND
+1.53
1.11%
Apellis Pharmaceuticals, Inc.
USD 19.47
APLS
-0.57
-2.84%
NewAmsterdam Pharma Company N.V.
USD 22.20
NAMS
+0.22
1.00%
Apogee Therapeutics, Inc.
USD 39.31
APGE
+0.31
0.80%
Bavarian Nordic A/S
USD 28.67
BAVA.CO
+0.39
1.37%
Immunocore Holdings plc
USD 36.31
IMCR
+0.10
0.28%
ARS Pharmaceuticals, Inc.
USD 17.92
SPRY
-0.43
-2.34%
AbbVie Inc.
USD 189.26
ABBV
-2.14
-1.12%
Novo Nordisk A/S
USD 64.39
NOVO-B.CO
-1.34
-2.03%
Roche Holding AG
USD 340.88
RO.SW
+2.44
0.72%